Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06049654

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Led by Fundación EPIC · Updated on 2025-12-19

104

Participants Needed

9

Research Sites

143 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.

CONDITIONS

Official Title

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 65 18 years
  • Severe haemodynamical valve deterioration of a biological aortic valve implanted surgically, including severe valve stenosis (effective aortic valve area < 1.0 cm2) and/or severe valve regurgitation
  • Patient has cardiac symptoms and/or deterioration of left ventricular ejection fraction due to the aortic valve disease
  • Heart team decision for valve-in-valve procedure
  • Patient is willing to return at 30 days for echocardiography and to be contacted clinically at 1 year
Not Eligible

You will not qualify if you...

  • Patients who openly refuse to participate in the study
  • Female patients who are pregnant
  • Presence or suspicion of biological aortic valve thrombosis
  • Known allergy or contraindication to antithrombotic therapy, nitinol, or contrast media that cannot be pre-treated
  • Ongoing sepsis or suspicion/diagnosis of endocarditis
  • Life expectancy less than 1 year due to non-cardiac conditions
  • Medical, social, or psychological issues preventing consent or follow-up adherence
  • Prosthetic valve inner diameter greater than 27 mm
  • Inadequate transfemoral access for an 18F sheath
  • Participation in other clinical trials (except registries)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Spain, 08907

Actively Recruiting

2

Hospital Clinico San Carlos

Madrid, Spain, 28040

Actively Recruiting

3

Hospital Universitario de La Paz

Madrid, Spain, 28046

Actively Recruiting

4

Hospital Universitario Puerta De Hierro

Majadahonda, Spain, 28222

Actively Recruiting

5

Hospital Clínico Universitario de Salamanca

Salamanca, Spain, 37007

Actively Recruiting

6

Hospital Universitari I Politècnic de La Fe

Valencia, Spain, 46026

Actively Recruiting

7

Manchester University NHS Foundation Trust

Manchester, United Kingdom

Actively Recruiting

8

Freeman Hospital

Newcastle, United Kingdom

Actively Recruiting

9

Morriston Hospital, Swansea

Swansea, United Kingdom

Actively Recruiting

Loading map...

Research Team

R

RAÚL MORENO GÓMEZ, MD, PhD

CONTACT

F

FUNDACION EPIC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here